CBIO earnings
Crescent Biopharma (CBIO) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- CBIO beat EPS estimates in 4 of its last 13 reports.
CBIO earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 12, 2026 | -0.90 | – | – | $3.12M |
| Q2 2026 | Jul 30, 2026 | -0.74 | -0.74 | -0.58% | $0.00 |
| Q1 2026 | Apr 29, 2026 | -0.70 | – | – | $1.04M |
| Q3 2025 | Nov 6, 2025 | -1.27 | -1.01 | -25.74% | $0.00 |
| Q2 2025 | Jul 31, 2025 | -4.93 | -2.69 | -83.27% | $0.00 |
| Q1 2025 | May 14, 2025 | -0.04 | -5.00 | 99.20% | $0.00 |
| Q4 2024 | Feb 13, 2025 | -0.11 | -0.16 | 31.25% | – |
| Q3 2024 | Nov 13, 2024 | -0.15 | -0.11 | -36.36% | – |
| Q1 2024 | May 9, 2024 | -0.17 | -0.16 | -6.25% | – |
| Q4 2023 | Mar 27, 2024 | -0.14 | -0.15 | 6.67% | $10.00K |
| Q3 2023 | Nov 3, 2023 | -14.00 | -0.14 | -9900.00% | – |
| Q2 2023 | Aug 2, 2023 | -13.00 | -0.18 | -7122.22% | – |
| Q1 2023 | May 3, 2023 | -17.00 | -0.17 | -10099.80% | – |
| Q4 2022 | Mar 29, 2023 | -19.00 | -0.17 | -11299.77% | $0.00 |
| Q3 2022 | Nov 9, 2022 | -0.16 | -0.25 | 36.00% | $0.00 |